INFORECERCA: Butlletí Informatiu del Servei de Recerca de l'IMIM
Número: 445
19/02/2016
Comentaris i suggeriments
Banner-noves-convocatories-02
Cercador de convocatòries
Projectes
Termini exhaurit
COMISSIÓ EUROPEA
The Joint Programming Initiative "A Healthy Diet for a Healthy Life" (JPI HDHL) has been established to coordinate research in the areas of food, diet, physical activity and health in order to achieve tangible societal and health impact and to strengthen European leadership and competitiveness in this field.

The call "Biomarkers for Nutrition and Health" (BioNH)l will focus on the identification and validation of biomarkers that are modulated by diet and that indicate a change in health status and/or the risk of developing diet-related diseases. Biomarkers of physical activity may be considered alongside diet.
 
Termini exhaurit
FUNDACIÓ LA MARATÓ DE TV3
Fomentar la recerca científica d’excel·lència sobre aspectes etiològics, patogènics, clínics, terapèutics, epidemiològics, de salut pública i de serveis sanitaris, en l’àmbit de la diabetis i l’obesitat, com a elements nuclears del projecte.
 
Termini exhaurit
CURE - Citizens United for Research in Epilepsy
Citizens United for Research in Epilepsy (CURE), is a leading nongovernmental agency fully committed to funding research in epilepsy.

The CURE Innovator Award supports the exploration of a highly innovative, often risky new concept or untested theory that addresses an important problem relevant to epilepsy. The Innovator Award proposed research must reflect ideas substantially different from those being pursued by anyone in the epilepsy research field. The program is not intended to support the logical progression of an already established research project but, instead, allows Principal Investigators (PIs) the opportunity to pursue radically unconventional, paradigm-shifting hypotheses. CURE AwardsThis award mechanism supports high-risk studies that have the potential to reveal entirely new areas of epilepsy research.
Research completed through an Innovator Award must provide sufficient preliminary data to enable the PI to prove or disprove their groundbreaking, original, and/or unconventional hypothesis and have the potential, if the scope of work is successful, to move epilepsy research forward by leaps rather than by incremental steps.
 
Termini exhaurit
CURE - Citizens United for Research in Epilepsy
Citizens United for Research in Epilepsy (CURE), is a leading nongovernmental agency fully committed to funding research in epilepsy.

CURE’s investigator-initiated grants program seeks to push the envelope and accelerate promising research leading to disease-modifying breakthroughs for people living with epilepsy. CURE prioritizes highly innovative, risky, paradigm-shifting projects that address CURE’s mission to cure epilepsy, affirming our core belief that the only acceptable final goal is “no seizures, no side-effects.”
CURE strongly encourages multidisciplinary, collaborative projects, especially those that include investigators and expertise from fields outside of epilepsy.

2016 Priority areas
  • Transformative research to enhance our understanding of the cellular, molecular, genetic and systems-level mechanisms that lead to any of the epilepsies, facilitating the continued investigation of disease-modifying or preventative strategies
  • Innovative approaches that can prevent, modify and/or arrest the development of acquired epilepsy after head injury, stroke, tumor, viral infection, etc.
  • Research that will inform the development of novel therapies to prevent onset or halt the progression of the severe pediatric epilepsies
  • Research focused on new, effective treatments for the >30% of the epilepsy population who are pharmacoresistant
  • Novel research that furthers our understanding of the causes and ultimate elimination of SUDEP

    Based on CURE’s current research objectives, lower priority will be given for research in the following areas:
  • Research that focuses solely on a comorbid condition without also seeking to address/understand the accompanying epilepsy
  • Research that focuses solely on improving localization of the epileptic seizure focus
    		•
     
    Termini exhaurit
    CURE - Citizens United for Research in Epilepsy
    Citizens United for Research in Epilepsy (CURE), is a leading nongovernmental agency fully committed to funding research in epilepsy.

    The CURE Taking Flight Award seeks to promote the careers of young investigators to allow them to develop a research focus independent of their mentor(s). Researchers may propose basic or clinical studies, but this award mechanism is not intended to support clinical trials. Research that involves collaboration and a multidisciplinary approach is desirable. Applicant will be required to discuss how this avenue of research is independent from his or her mentor’s research, and will lead him or her to a path of independent epilepsy research. We encourage studies that will provide new directions for epilepsy therapy, prevention and, ultimately, a cure and that will allow applicants to collect the data necessary to support a National Institutes of Health grant application
     
    Termini exhaurit
    RED ESPAÑOLA DE ATENCIÓN PRIMARIA
    La xarxa espanyola d'Atenció Primària convoca ajudes per projectes que s'apliquin i desenvolupin en el camp de l'Atenció Primària.
     
    Termini exhaurit
    FUNDACIÓN TATIANA PÉREZ DE GUZMÁN EL BUENO
    Promoure la investigació científica convocant ajudes d'investigació en Neurociència per a investigadors que realitzin el seu treball a Espanya.
    L'objectiu de les ajudes és finançar la realització de projectes d'investigació en Neurociència enfocats a la comprensió del sistema nerviós humà i de les malalties que l'afecten.
     
    Termini exhaurit
    ACANPAN - ASOCIACIÓN CÁNCER DE PÁNCREAS
    Finançar estudis relacionats amb la recerca en el diagnòstic i/o tractament del adenocarcinoma de pàncrees.
     
    Altres
    Termini exhaurit
    COST (COOPERACIÓ EUROPEA EN L'ÀMBIT DE LA RECERCA CIENTIFICA I TÈCNICA)
    COST actions are a Pan-European networking instrument that allows researchers, engineers or scholars from COST Member Countries and Cooperating State to develop jointly their ideas and new initiatives in a field or topic of common interest.
    COST supports the following networking tools: Meetings, Conferences, Workshops, Short-term scientific exchanges, Training schools and Dissemination Activities. COST does not support research
     
    Borses de viatge
    Termini exhaurit
    EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER
    The European Association for the Study of the Liver is a major European Association with international influence dedicated to the liver and liver disease. EASL has over 4,000 members from all over the world and provides an annual platform, The International Liver Congress™, for 11,000 liver experts to meet and discuss latest scientific research.

    The Andrew K. Burroughs Short-Term Training Fellowship is open to all registered EASL members, and its aim is to enhance the mobility of investigators within different European institutions through actively promoting scientific exchange among research units in Hepatology.
     
    Termini exhaurit
    FUNDACIÓN RAMÓN ARECES
     
    Premis
    Termini exhaurit
    EUROPEAN RESPIRATORY SOCIETY
    ERS is the leading professional organisation in its field in Europe. It is broad-based, with some 10,000 members and counting in over 100 countries. Its scope covers both basic science and clinical medicine. ERS seeks to alleviate suffering from respiratory disease and promote lung health through research, sharing of knowledge and through medical and public education.
     
    Termini exhaurit
    EUROPEAN RESPIRATORY SOCIETY
    ERS is the leading professional organisation in its field in Europe. It is broad-based, with some 10,000 members and counting in over 100 countries. Its scope covers both basic science and clinical medicine. ERS seeks to alleviate suffering from respiratory disease and promote lung health through research, sharing of knowledge and through medical and public education.
     
    Termini exhaurit
    EUROPEAN RESPIRATORY SOCIETY
    ERS is the leading professional organisation in its field in Europe. It is broad-based, with some 10,000 members and counting in over 100 countries. Its scope covers both basic science and clinical medicine. ERS seeks to alleviate suffering from respiratory disease and promote lung health through research, sharing of knowledge and through medical and public education.
     
    Termini exhaurit
    EUROPEAN RESPIRATORY SOCIETY
    ERS is the leading professional organisation in its field in Europe. It is broad-based, with some 10,000 members and counting in over 100 countries. Its scope covers both basic science and clinical medicine. ERS seeks to alleviate suffering from respiratory disease and promote lung health through research, sharing of knowledge and through medical and public education.
     
    Termini exhaurit
    Universal Medica Events
     
    Recursos Humans
    Termini exhaurit
    FUNDACIÓN JOSÉ LUIS CASTAÑO
    La Societat Espanyola de Bioquímica Clínica i Patologia Molecular (SEQC) i la Fundació José Luis Castany, per al desenvolupament del Laboratori Clínic, anuncien la convocatòria de 7 beques post-residència, (3 finançades per la SEQC i 4 per la Fundació José Luis Castany) per a aquells facultatius especialistes del Laboratori Clínic que acabin el seu període de residència en el 2016, i que vulguin realitzar un projecte de recerca en un Laboratori Clínic d'un hospital o d'un centre nacional o internacional de reconegut prestigi.
     
     
     
    Informació últil
     
     
     
    Banner-convocatories-tancament-02
    Projectes
    Termini exhaurit
    FUNDACIÓ LA MARATÓ DE TV3
    Fomentar la recerca científica d’excel·lència sobre aspectes etiològics, patogènics, clínics, terapèutics, epidemiològics, de salut pública i de serveis sanitaris, en l’àmbit de la diabetis i l’obesitat, com a elements nuclears del projecte.
     
    Termini exhaurit
    COMISSIÓ EUROPEA
    The Joint Programming of the European Union aims to pool national research efforts in order to make better use of Europe’s public R&D resources and to tackle common European challenges more effectively.
    The primary aim of the third joint call of JPIAMR is to combine the resources, infrastructures, and research strengths of multiple countries in order to address transmission of antibiotic resistance following a ‘One Health Approach’. The goal is to foster multinational research collaborations to add value to and to build upon the research conducted independently at national level and to work together to improve the control of resistant bacterial infections of clinical and/or veterinary importance only.
     
    Termini exhaurit
    COMISSIÓ EUROPEA
    Infect-ERA is an ERA-NET on human infectious diseases funded under the Seventh Research Framework Programme .
    Infect-ERA will support scientific research involving all basic aspects of human infection biology caused by bacteria, fungi, viruses and protozoa. More precisely, research addressing the cross-talk between host and pathogens, as well as the relationship between microbes’ environment and infection are in the scope of Infect-ERA.
     
    Termini exhaurit
    COMISSIÓ EUROPEA
    ERA-NETs are projects funded by the European Commission in various research fields. Their goal is to create a European Research Area in which research is conducted and funded across countries, allowing research groups to jointly work on specific problems, exchange ideas, and benefit from cross border expertise.
    The current project NEURON II co-ordinates national and regional programmes for disease-related neuroscience research in 23 participant funding organisations across 14 European Member States, Israel as an Associated Country, and Norway and Canada.
     
    Termini exhaurit
    COMISSIÓ EUROPEA
    ERA-CVD is a newly established European Research Area Network (ERA-Net) comprising 23 Partners from 18 countries/regions. The goal of ERA-CVD is to create a European Research Area in which cardiovascular research is conducted and funded across countries, allowing research groups to jointly work on specific problems, exchange ideas, and benefit from cross border expertise.
     
    Termini exhaurit
    COMISSIÓ EUROPEA
    ERANet-LAC is a Network of the European Union (EU) and the Community of Latin American and Caribbean States (CELAC) on Joint Innovation and Research Activities. It strengthens the bi-regional partnership in Science, Technology and Innovation by planning and implementing concrete joint activities and by creating a sustainable framework for future bi-regional joint activities.
     
    Termini exhaurit
    FUNDACIÓN PRIVADA PREVENT
    Fomentar i impulsar la recerca en l'àmbit de la prevenció de riscos laborals des del vessant científic i d'aplicació pràctica en la prevenció de riscos laborals. Els projectes han de ser projectes inequívocament de recerca en l'àmbit de la seguretat i la salut laboral, descartant-se tots aquells que el Comitè Científic consideri que no s'ajusten a aquesta descripció.
    Millorar, mitjançant la recerca, les condicions de seguretat i salut laboral de tots els treballadors, i especialment, la dels treballadors especialment sensibles als riscos laborals.
     
    Termini exhaurit
    CURE - Citizens United for Research in Epilepsy
    Citizens United for Research in Epilepsy (CURE), is a leading nongovernmental agency fully committed to funding research in epilepsy.

    The CURE Innovator Award supports the exploration of a highly innovative, often risky new concept or untested theory that addresses an important problem relevant to epilepsy. The Innovator Award proposed research must reflect ideas substantially different from those being pursued by anyone in the epilepsy research field. The program is not intended to support the logical progression of an already established research project but, instead, allows Principal Investigators (PIs) the opportunity to pursue radically unconventional, paradigm-shifting hypotheses. CURE AwardsThis award mechanism supports high-risk studies that have the potential to reveal entirely new areas of epilepsy research.
    Research completed through an Innovator Award must provide sufficient preliminary data to enable the PI to prove or disprove their groundbreaking, original, and/or unconventional hypothesis and have the potential, if the scope of work is successful, to move epilepsy research forward by leaps rather than by incremental steps.
     
    Termini exhaurit
    CURE - Citizens United for Research in Epilepsy
    Citizens United for Research in Epilepsy (CURE), is a leading nongovernmental agency fully committed to funding research in epilepsy.

    CURE’s investigator-initiated grants program seeks to push the envelope and accelerate promising research leading to disease-modifying breakthroughs for people living with epilepsy. CURE prioritizes highly innovative, risky, paradigm-shifting projects that address CURE’s mission to cure epilepsy, affirming our core belief that the only acceptable final goal is “no seizures, no side-effects.”
    CURE strongly encourages multidisciplinary, collaborative projects, especially those that include investigators and expertise from fields outside of epilepsy.

    2016 Priority areas
  • Transformative research to enhance our understanding of the cellular, molecular, genetic and systems-level mechanisms that lead to any of the epilepsies, facilitating the continued investigation of disease-modifying or preventative strategies
  • Innovative approaches that can prevent, modify and/or arrest the development of acquired epilepsy after head injury, stroke, tumor, viral infection, etc.
  • Research that will inform the development of novel therapies to prevent onset or halt the progression of the severe pediatric epilepsies
  • Research focused on new, effective treatments for the >30% of the epilepsy population who are pharmacoresistant
  • Novel research that furthers our understanding of the causes and ultimate elimination of SUDEP

    Based on CURE’s current research objectives, lower priority will be given for research in the following areas:
  • Research that focuses solely on a comorbid condition without also seeking to address/understand the accompanying epilepsy
  • Research that focuses solely on improving localization of the epileptic seizure focus
    		•
     
    Termini exhaurit
    CURE - Citizens United for Research in Epilepsy
    Citizens United for Research in Epilepsy (CURE), is a leading nongovernmental agency fully committed to funding research in epilepsy.

    The CURE Taking Flight Award seeks to promote the careers of young investigators to allow them to develop a research focus independent of their mentor(s). Researchers may propose basic or clinical studies, but this award mechanism is not intended to support clinical trials. Research that involves collaboration and a multidisciplinary approach is desirable. Applicant will be required to discuss how this avenue of research is independent from his or her mentor’s research, and will lead him or her to a path of independent epilepsy research. We encourage studies that will provide new directions for epilepsy therapy, prevention and, ultimately, a cure and that will allow applicants to collect the data necessary to support a National Institutes of Health grant application
     
    Termini exhaurit
    ASOCIACIÓN ESPAÑOLA DE PEDIATRÍA
    El projecte d'investigació haurà de versar sobre un tema lliure de Pediatria valorant-se especialment els projectes multicèntrics i/o internivells assistencials.
     
    Termini exhaurit
    BILL & MELINDA GATES FOUNDATION
     
    Termini exhaurit
    FUNDACIÓN MUTUA MADRILEÑA
    Mitjançant aquesta XII Convocatòria es concediran un màxim de 15 ajudes a equips d'investigadors amb reconeguda experiència, que treballin en els següents camps d'investigació:
  • Oncologia. Centrada en tumors sòlids en la infància;
  • Trasplantament. Referint-nos exclusivament a vies de millora en l'obtenció i utilització d'òrgans per a trasplantament
  • Traumatologia i seqüeles, tant traumatològiques com neurològiques.
  • Malalties rares. Limitada a les quals es manifesten clínicament durant la infància.
    Els projectes que es presentin a aquesta convocatòria haurien de ser exclusivament treballs d'investigació clínica
    •  
    Termini exhaurit
    SOCIEDAD ESPAÑOLA DE ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA
    Amb aquesta convocatòria la SEIMC vol facilitar la recerca traslacional de qualitat en Malalties Infeccioses i Microbiologia Clínica, proporcionant als socis el finançament necessari per a això.
    La convocatòria té un objectiu principal:
    - Seleccionar projectes que produeixin un impacte elevat en salut, que siguin capaces de modificar la pràctica estàndard.
    - Es valorarà positivament que el projecte tingui potencial per facilitar la posterior consecució d'un projecte europeu.
     
    Termini exhaurit
    FUNDACIÓN ALICIA KOPLOWITZ
    Promoure el desenvolupament del coneixement a Espanya de la Psiquiatria, Psicologia i/o Neurociències del Nen i l'Adolescent mitjançant el suport a Projectes de Recerca originals.
    S'atorgaran 7 ajudes a la recerca.
     
    Termini exhaurit
    MINECO - MINISTERIO DE ECONOMÍA Y COMPETITIVIDAD
    L'objectiu de la convocatòria Reptes-Col·laboració és el suport a projectes en cooperació entre empreses i organismes d'investigació, amb la finalitat de promoure el desenvolupament de noves tecnologies, l'aplicació empresarial de noves idees i tècniques, i contribuir a la creació de nous productes i serveis.
     
    Termini exhaurit
    LADY TATA MEMORIAL TRUST
     
    Termini exhaurit
    PROSTATE CANCER FOUNDATION
    The Prostate Cancer Foundation (www.pcf.org) champions investment in human capital to fast-forward solutions for prostate cancer with the ultimate goal of ending death and suffering from metastatic prostate cancer.
    Research proposals submitted in consideration for the Young Investigator Award should, if successful, provide high impact to the field. “Small-step” or incremental proposals are usually non-competitive. Highly innovative basic science programs will be carefully considered, but priority will be given to “bench to bedside” translational research proposals with the potential to deliver near term benefit to patients.
     
    Termini exhaurit
    FJL - FONDATION JEROME LEJEUNE
    The main target of the Fondation Jerome Lejeune, a non profit foundation, is research into genetic diseases with intellectual disability.
     
    Termini exhaurit
    HUMAN FRONTIER SCIENCE PROGRAMME
    The Human Frontier Science Program (HFSP) is a niche program that supports innovative basic research into fundamental biological problems with emphasis placed on novel and interdisciplinary approaches that involve scientific exchanges across national and disciplinary boundaries. The participation of scientists from disciplines outside the traditional life sciences such as biophysics, chemistry, computational biology, computer science, engineering, mathematics, nanoscience or physics has made biological research increasingly quantitative and will continue to do so. Such collaborations have opened up new approaches for understanding the complex structures and regulatory networks that characterize living organisms, their evolution and interactions.
     
    Altres
    Termini exhaurit
    COMISSIÓ EUROPEA
    JPND was established in 2009 to enable participating EU Member States to work together on the challenge of age-related neurodegenerative diseases, in particular Alzheimer’s. In the past five years, tremendous progress has been made by JPND in terms of increasing coordination, collaboration and alignment between national research programmes and projects related to neurodegenerative diseases.
     
    Borses de viatge
    Termini exhaurit
    EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER
    The European Association for the Study of the Liver is a major European Association with international influence dedicated to the liver and liver disease. EASL has over 4,000 members from all over the world and provides an annual platform, The International Liver Congress™, for 11,000 liver experts to meet and discuss latest scientific research.

    The Andrew K. Burroughs Short-Term Training Fellowship is open to all registered EASL members, and its aim is to enhance the mobility of investigators within different European institutions through actively promoting scientific exchange among research units in Hepatology.
     
    Premis
    Termini exhaurit
    EUROPEAN RESPIRATORY SOCIETY
    ERS is the leading professional organisation in its field in Europe. It is broad-based, with some 10,000 members and counting in over 100 countries. Its scope covers both basic science and clinical medicine. ERS seeks to alleviate suffering from respiratory disease and promote lung health through research, sharing of knowledge and through medical and public education.
     
    Termini exhaurit
    EUROPEAN RESPIRATORY SOCIETY
    ERS is the leading professional organisation in its field in Europe. It is broad-based, with some 10,000 members and counting in over 100 countries. Its scope covers both basic science and clinical medicine. ERS seeks to alleviate suffering from respiratory disease and promote lung health through research, sharing of knowledge and through medical and public education.
     
    Termini exhaurit
    EUROPEAN RESPIRATORY SOCIETY
    ERS is the leading professional organisation in its field in Europe. It is broad-based, with some 10,000 members and counting in over 100 countries. Its scope covers both basic science and clinical medicine. ERS seeks to alleviate suffering from respiratory disease and promote lung health through research, sharing of knowledge and through medical and public education.
     
    Termini exhaurit
    EUROPEAN RESPIRATORY SOCIETY
    ERS is the leading professional organisation in its field in Europe. It is broad-based, with some 10,000 members and counting in over 100 countries. Its scope covers both basic science and clinical medicine. ERS seeks to alleviate suffering from respiratory disease and promote lung health through research, sharing of knowledge and through medical and public education.
     
    Termini exhaurit
    FUNDACION PREMIOS REY JAIME I
    El premi es concedirà a aquella persona que la seva tasca hagi estat altament significativa.
    Els candidats podran ser proposats per investigadors, universitats, acadèmies, col·legis professionals, hospitals, empreses, fundacions i altres.
     
    Termini exhaurit
    FUNDACIÓN CASER
    Per vuitè any consecutiu la Fundació Caser obre la convocatòria dels seus premis Dependència i Societat , amb l'objectiu de reconèixer les millors iniciatives en aquesta matèria, podran presentar-se les candidatures a qualsevol de les tres categories que integren aquests guardons a:
  • Excel·lència en Dependencia
  • R+D en Dependencia
  • Comunicació en Dependència
    		•
     
    Recursos Humans
    Termini exhaurit
    EUROPEAN HEMATOLOGY ASSOCIATION
    The EHA-JSH Collaborative Exchange Program is intended to provide European and Japanese research institutes the opportunity to exchange scientists and clinical researchers reciprocally for a short period.
     
     
     
     
    Articles
     
    Toll A, Fonseca F, Francisco E, Bergé D, Pérez V, Torrens M*. Concomitant Treatment of Tobacco Dependence during the Admission for Detoxification of Other Drug of Abuse: Evaluation at 6 Months Follow-Up after Discharge. Austin J Drug Abuse and Addict 2015; 2(1): id1006.
     
    Sánchez-Martín FJ, Bellosillo B, Gelabert M, Dalmases A, Cañadas I, Vidal J, Martínez-Fernández A, Argiles G, Siravegna G, Arena S, Koefoed K, Visa L, Arpí O, Horak ID, Iglesias M, Stroch C, Kragh M, Rovira A, Albanell J, Tabernero J, Bardelli A, Montagut C*. The first-in-class anti-EGFR antibody mixture Sym004 overcomes cetuximab-resistance mediated by EGFR extracellular domain mutations in colorectal cancer. Clin Cancer Res 2016; 22(13): 3260-3267.
     
    Castells X*, Torá-Rocamora I, Posso M, Román M, Vernet-Tomas M, Rodriguez-Arana AM, Domingo L, Vidal C, Baré M, Ferrer J, Quintana MJ, Sánchez M, Natal C, Espinàs JA, Saladie F, Sala M, for the BELE Study Group. Risk of Breast Cancer in Women with False-Positive Results according to Mammographic Features. Radiology 2016; 280(2): 379-386.
     
    Warner A, Dahele M, Hu B, Palma DA, Senan S, Oberije C, Tsujino K, Moreno-Jimenez M, Kim TH, Marks LB, Rengan R, De Petris, Ramella S, De Ruyck, Rodriguez de Dios N, Bradley JD, Rodrigues G*. Factors Associated With Early Mortality in Patients Treated With Concurrent Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer. Int J Radiat Oncol 2016; 94(3): 612-20.
     
    Guo X, Tresserra Rimbau A, Estruch Riba R, Martínez-González MA, Medina-Remón A, Castañer O, Corella D, Salas Salvadó J, Lamuela-Raventos RM*. Effects of Polyphenol, Measured by a Biomarker of Total Polyphenols in Urine, on Cardiovascular Risk Factors After a Long-Term Follow-Up in the PREDIMED Study. Oxid Med Cell Longev 2016; 2016: 2572606.
     
    Pastor A, Rodríguez-Morató J, Olesti E, Pujadas-Bastardes M, Pérez-Mañá C, Khymenets O, Fitó Colomer M, Covas MI, Solá R, Motilva MJ, Farré M, de la Torre R*. Analysis of free hydroxytyrosol in human plasma following the administration of olive oil. J Chromatogr A 2016; 1437: 183-190.
     
    Larriba MJ*, García de Herreros A, Muñoz A*. Vitamin D and the Epithelial to Mesenchymal Transition. Stem Cells Int 2016; 2016: 6213872.
     
    Vaquerizo B*, Barros A, Pujadas S, Bajo E, Jiménez M, Gomez-Lara J, Jacobi F, Salvatella N, Pons G, Serra A, Cinca J. One-Year Results of Bioresorbable Vascular Scaffolds for Coronary Chronic Total Occlusions. Am J Cardiol 2016; 117(6): 906-917.
     
    Novo-Navarro P, Landin-Romero R, Guardiola-Wanden-Berghe R, Moreno-Alcázar A, Valiente-Gómez A, Lupo W, García F, Fernández I, Pérez V, Amann BL*. 25 años de Eye Movement Desensitization and Reprocessing: protocolo de aplicación, hipótesis de funcionamiento y revisión sistemática de su eficacia en el trastorno por estrés postraumático. Rev Psiquiatr Salud Ment 2018; 11(2): 101-114.
     
    Teixidor P, Arráez MÁ, Villalba G, García R, Tardáguila M, González JJ, Rimbau J, Vidal X, Montané E*. Safety and Efficacy of 5-Aminolevulinic Acid for High Grade Glioma in Usual Clinical Practice: A Prospective Cohort Study. PLoS ONE 2016; 11(2): e0149244.
     
    Ventura R, Matabosch X, Segura J. Bioanalytical techniques in discrimination between therapeutic and abusive use of drugs in sport. Bioanalysis 2016; 8(9): 965-980.
     
    Rubio MA, Herrando-Grabulosa M, Vilches JJ, Navarro X*. Involvement of sensory innervation in the skin of SOD1G93A ALS mice. J Peripher Nerv Syst 2016; 21(2): 88-95.
     
    Ramos R*, García-Gil M, Comas-Cufí M, Quesada M, Marrugat J, Elosua R, Sala J, Grau M, Martí R, Ponjoan A, Alves-Cabratosa L, Blanch J, Bolíbar B. Statins for Prevention of Cardiovascular Events in a Low-Risk Population With Low Ankle Brachial Index. J Am Coll Cardiol 2016; 67(2): 630-40.
     
    Stratakis N, Roumeliotaki T, Oken E, Barros H, Basterrechea M, Charles MA, Eggesbø M, Forastiere F, Gaillard R, Gehring U, Govarts E, Hanke W, Heude B, Iszatt N, Jaddoe VW, Kelleher C, Mommers M, Murcia M, Oliveira A, Pizzi C, Polanska K, Porta D, Richiardi L, Rifas Shiman SL, Schoeters G, Sunyer J, Thijs C, Viljoen K, Vrijheid M, Vrijkotte TG, Wijga AH, Zeegers MP, Kogevinas M, Chatzi L*. Fish Intake in Pregnancy and Child Growth: A Pooled Analysis of 15 European and US Birth Cohorts. JAMA Pediatr 2016; 170(4): 381-390.
     
    Sánchez-Velázquez P, Grande L, Pera M. Outpatient treatment of uncomplicated diverticulitis: a systematic review. Eur J Gastroenterol Hepatol 2016; 28(6): 622-627.
     
    Corral J*, Castells X, Molins E, Chiarello P, Borràs JM, Cots F. Long-term costs of colorectal cancer treatment in Spain. BMC Health Serv Res 2016; 16(1): 56.
     
    Trucco ME, Tolosana JM*, Arbelo E, Méndez FJ, Viñolas X, Anguera I, Dallaglio P, Villuendas R, Pereferrer-Kleiner D, Pérez-Rodón J, Roca-Luque I, Mercé J, Badarjí A, Martí Almor J, Vallès E, Berruezo A, Sitges M, Brugada J, Mont L. Estado actual del tratamiento de resincronización cardiaca en Cataluña: resultados del estudio prospectivo multicéntrico TRC-CAT. Med Clin (Barc) 2016; 146(10): 423-428.
     
     
    Institut Hospital del Mar d'Investigacions Mèdiques
    Tel: 93 316 04 00
    Doctor Aiguader, 88
    08003 Barcelona
    Seguiu-nos a:
    Twitter
    Youtube
    En compliment de la Llei 34/2002, de Serveis de la Societat de la Informació i de Comerç Electrònic, aquest correu li hem enviat a partir de les dades de contacte que vostè ens ha facilitat. Si vostè no desitja rebre més comunicats, pot donar-se de baixa dirigint-se per escrit al Servei de Recursos Humans-IMIM (RRHHconfidencialitat@imim.es) tot indicant la paraula “baixa base de dades” a l’assumpte.
    Li recordem que podrà exercir els drets d’accés, rectificació, cancel·lació i oposició dirigint-se per escrit al Servei de Recursos Humans-IMIM (RRHHconfidencialitat@imim.es).